Could GLP-1 Drugs Reduce Obesity-Related Cancers in the Future?
Key TakeawaysObesity and overweight are linked to a higher risk of many common cancers.Research has suggested that GLP-1 drugs, like Wegovy and Zepbound, may play a role in improving the function of certain anti-cancer cells.Although maintaining a healthy weight may reduce cancer risk, current guidelines emphasize achieving this through diet and physical activity rather than weight-management drugs.Obesity and overweight are associated with a higher risk ofat least 13 types of cancer, including breast, kidney, and colorectal cancer....